Industries · Infectious Diseases & Microbiome
OMICS4 combines host transcriptomics and microbiome profiling to help researchers understand host-pathogen interactions and microbial community dynamics, in-house and with our infectious-disease partner.
Overview
OMICS4 combines host transcriptomics and microbiome profiling to help researchers understand host-pathogen interactions and microbial community dynamics in infectious disease research. Specialist infectious-disease expertise is available through our partner IHU Méditerranée Infection, alongside our in-house sequencing and metagenomics platforms.
OMICS4 capabilities
Host and pathogen transcriptional dynamics across infection time-course.
Community composition and function tracked longitudinally.
Host biomarker candidates quantified and validated across cohorts.
Combined host + microbiome models, delivered by GenXMap's Computational Biology & AI layer on top of our wet-lab data.
How OMICS4 adapts
No two programs run the same workflow. Here is how OMICS4 fits into what you already have in place.
Samples can be biosafety-sensitive (BSL-2/3 pathogens) and require specific handling chains.
Sample logistics and lab handling are scoped to your biosafety and containment requirements from intake.
Studies often combine hospital, field, and lab-collected samples of variable quality.
QC thresholds and processing are adapted per sample source rather than applying one blanket standard.
Findings need to connect to epidemiological or clinical severity data, not just molecular signal.
Molecular results are delivered alongside your clinical/epidemiological metadata for direct interpretation.
Some programs (public health, outbreak response) run on compressed timelines.
Turnaround is scoped to the urgency of the program, from standard R&D pace to rapid-response windows.
Have a project in this space?